86
Participants
Start Date
December 10, 2024
Primary Completion Date
February 28, 2025
Study Completion Date
March 31, 2025
Pethidine Hydrochloride 50 Mg/mL Solution for Injection
Pethidine will be administered intravenously in group A 0.5 mg/kg as premedication
Pethidine Hydrochloride 50 Mg/mL Solution for Injection administered intrathecally
0.2 mg/kg pethidine in trathecally will be administered with bupivacaine 0.5% in group B
RECRUITING
El-Shatby University Hospital, Alexandria
Alexandria University
OTHER